Qiang Lü

4.4k total citations · 2 hit papers
132 papers, 3.1k citations indexed

About

Qiang Lü is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Qiang Lü has authored 132 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Surgery, 57 papers in Molecular Biology and 44 papers in Cancer Research. Recurrent topics in Qiang Lü's work include Bladder and Urothelial Cancer Treatments (44 papers), Cancer-related molecular mechanisms research (23 papers) and MicroRNA in disease regulation (22 papers). Qiang Lü is often cited by papers focused on Bladder and Urothelial Cancer Treatments (44 papers), Cancer-related molecular mechanisms research (23 papers) and MicroRNA in disease regulation (22 papers). Qiang Lü collaborates with scholars based in China, United States and Germany. Qiang Lü's co-authors include Xiao Yang, Haiwei Yang, Jie Han, Hao Yu, Zijian Zhou, Wenbo Yuan, Ji‐Fu Wei, Jun Tao, Hongcheng Lu and Rui Zhou and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Qiang Lü

121 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner

2019 546 citations Jie Han, Xiao Yang et al. Molecular Cancer profile →
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer

2021 205 citations Jie Han, Xiao Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qiang Lü China	28	2.3k	1.6k	528	366	305	132	3.1k
Xiaoshun He China	23	1.6k 0.7×	982 0.6×	511 1.0×	339 0.9×	221 0.7×	115	2.6k
Jiaxing Zhang China	28	2.2k 1.0×	1.6k 1.0×	182 0.3×	535 1.5×	356 1.2×	60	3.0k
Zipeng Lu China	25	1.2k 0.5×	848 0.5×	335 0.6×	867 2.4×	194 0.6×	104	2.2k
Kan Gong China	24	1.1k 0.5×	747 0.5×	315 0.6×	339 0.9×	631 2.1×	116	1.9k
Blanche Schroen Netherlands	32	3.4k 1.5×	2.7k 1.7×	652 1.2×	385 1.1×	259 0.8×	63	5.5k
Lixia Xu China	30	1.6k 0.7×	966 0.6×	258 0.5×	622 1.7×	399 1.3×	106	2.8k
Yanan Kong China	28	1.7k 0.7×	1.3k 0.8×	215 0.4×	699 1.9×	499 1.6×	78	2.8k
Wei He China	27	1.3k 0.6×	797 0.5×	338 0.6×	558 1.5×	526 1.7×	134	2.9k
Junchao Guo China	24	912 0.4×	522 0.3×	462 0.9×	1.1k 3.0×	338 1.1×	104	2.2k

Countries citing papers authored by Qiang Lü

Since Specialization

Citations

This map shows the geographic impact of Qiang Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Lü more than expected).

Fields of papers citing papers by Qiang Lü

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiang Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Lü. The network helps show where Qiang Lü may publish in the future.

Co-authorship network of co-authors of Qiang Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Lü. A scholar is included among the top collaborators of Qiang Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Lü. Qiang Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Yusheng, Yi Li, Xiaodong Zhang, et al.. (2025). Radiomics‐Based Unsupervised Clustering Identifies Subtypes Associated With Prognosis and Immune Microenvironment in Clear Cell Renal Cell Carcinoma: A Multicenter Study. Advanced Science. 12(34). e06165–e06165. 1 indexed citations

Liu, Peikun, Meihua Jiang, Bo Liang, et al.. (2025). Evaluating biparametric MRI for diagnosing muscle-invasive bladder cancer with variant urothelial histology: a multicenter study. Cancer Imaging. 25(1). 15–15.

Zhou, Ming, Hao Yu, Rui Zhou, et al.. (2024). CircFAM64A(3) promoted bladder cancer proliferation and inhibited CD8 + T cell via sponging to miR-149-5p and activated IL-6/JAK/STAT pathway. International Immunopharmacology. 145. 113762–113762. 2 indexed citations

Ding, Meijie, Zhiqiang Wei, Dexue Liu, et al.. (2024). Electronic modulation towards MOFs as template derived CoP via engineered heteroatom defect for a highly efficient overall water splitting. Journal of Energy Chemistry. 101. 598–607. 27 indexed citations

Cao, Qiang, et al.. (2024). MRI‐Based Machine Learning Radiomics for Preoperative Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Bladder Carcinoma. Journal of Magnetic Resonance Imaging. 60(6). 2694–2704. 5 indexed citations

Yu, Hao, Zijian Zhou, Jiancheng Lv, et al.. (2024). METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway. International Journal of Biological Sciences. 20(4). 1471–1491. 22 indexed citations

Yang, Xiao, et al.. (2024). Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node‐positive bladder cancer: Results of a prospective study.. Journal of Clinical Oncology. 42(4_suppl). 619–619. 1 indexed citations

Chen, Zhiying, Chunxiao Chen, Xue Fu, et al.. (2023). Unsupervised image-to-image translation in multi-parametric MRI of bladder cancer. Engineering Applications of Artificial Intelligence. 124. 106547–106547. 4 indexed citations

Zhou, Fusheng, et al.. (2023). The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies. Oncotarget. 14(1). 997–1008.

10.

Cao, Qiang, Peikun Liu, Kai Li, et al.. (2023). Development and Validation of an MRI‐Based Nomogram for Preoperative Detection of Muscle Invasion in VI‐RADS 3. Journal of Magnetic Resonance Imaging. 60(2). 448–457. 4 indexed citations

11.

Niu, Yue, Xiaoping Yu, Lu Wen, et al.. (2023). Comparison of preoperative CT- and MRI-based multiparametric radiomics in the prediction of lymph node metastasis in rectal cancer. Frontiers in Oncology. 13. 1230698–1230698. 11 indexed citations

12.

Lv, Jiancheng, Xiao Yang, Jie Han, et al.. (2021). Identification of the circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Bioinformatics Analysis. International Journal of Genomics. 2021. 1–22. 3 indexed citations

13.

Siemer, Svenja, Desirée Wünsch, Qiang Lü, et al.. (2020). Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy. Nanomaterials. 10(2). 383–383. 28 indexed citations

14.

Zhang, Xiaolei, Feng Wang, Zijie Wang, et al.. (2020). ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner. Annals of Translational Medicine. 8(10). 646–646. 60 indexed citations

15.

Han, Jie, Xiao Yang, Hao Yu, et al.. (2019). METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Molecular Cancer. 18(1). 110–110. 546 indexed citations breakdown →

16.

Li, Peng, Xiao Yang, Yidong Cheng, et al.. (2017). MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1. Cellular Physiology and Biochemistry. 41(3). 921–932. 81 indexed citations

17.

Liu, Yiyang, Jian Qian, Meiling Bao, et al.. (2015). miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells. DNA and Cell Biology. 34(6). 429–436. 58 indexed citations

18.

Yang, Xiao, Pengchao Li, Jun Tao, et al.. (2014). Association betweenNFKB1−94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis. International Journal of Genomics. 2014. 1–8. 26 indexed citations

19.

Yang, Xiao, Pengchao Li, Chao Qin, et al.. (2013). TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population. International Journal of Genomics. 2013. 1–9. 2 indexed citations

20.

Hu, Zhiquan, Zhaohui Zhong, Liping Xie, et al.. (2009). Fluid intake and the risk of bladder cancer: Results from the South and East China case‐control study on bladder cancer. International Journal of Cancer. 127(3). 638–645. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact